{ "@context": "http:\/\/schema.org", "@type": "Article", "image": "https:\/\/sandiegouniontribune.sergipeconectado.com\/wp-content\/s\/2025\/05\/SUT-L-Novartis-headquarters-0501-01.jpg?w=150&strip=all", "headline": "Novartis to acquire San Diego-based Regulus in deal worth up to $1.7B", "datePublished": "2025-05-01 15:52:16", "author": { "@type": "Person", "workLocation": { "@type": "Place" }, "Point": { "@type": "Point", "Type": "Journalist" }, "sameAs": [ "https:\/\/sandiegouniontribune.sergipeconectado.com\/author\/gqlshare\/" ], "name": "gqlshare" } } Skip to content
Business | Novartis to acquire San Diego-based Regulus in…
64°F
Tuesday, June 10th 2025

e-Edition

Trending:

Business

Novartis to acquire San Diego-based Regulus in deal worth up to $1.7B

Access to potential breakthrough treatment for kidney disease is a key part of the deal

Fortune 500 pharmaceutical company Novartis has agreed to acquire San Diego-based Regulus Therapeutics in a deal potentially worth $1.7 billion. (Novartis)
Fortune 500 pharmaceutical company Novartis has agreed to acquire San Diego-based Regulus Therapeutics in a deal potentially worth $1.7 billion. (Novartis)
By | [email protected] | The San Diego Union-Tribune
UPDATED:

Access to potential breakthrough treatment for kidney disease is a key part of the deal

Subscribe to continue reading this article.

Already subscribed? To , click here.

Originally Published:

RevContent Feed

More in Business

Events